Recent Research Analysts’ Ratings Updates for Mirati Therapeutics (MRTX)
Several brokerages have updated their recommendations and price targets on shares of Mirati Therapeutics (NASDAQ: MRTX) in the last few weeks: 11/11/2023 – Mirati Therapeutics is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 11/7/2023 – Mirati Therapeutics was downgraded by analysts at Leerink Partnrs from an “outperform” rating […]
More Stories
Macron Affirms Support for Greenland Sovereignty Amid US Interest in Annexation
By Rachel Roberts French President Emmanuel Macron has reaffirmed his support for the sovereignty of the Danish territory of Greenland...
DOJ Releases More Epstein Files, Says Some Documents Contain False Claims
By Jack Phillips The Department of Justice (DOJ) on Tuesday morning released thousands of documents related to the now-deceased convicted...
House Oversight Committee Expands Investigation Into Minnesota Fraud
By Jackson Richman The House Oversight Committee expanded its investigation into fraud in Minnesota on Dec. 22. The committee has...
US Economy Expands 4.3 Percent in 3rd Quarter, Topping Expectations
By Andrew Moran Robust consumer spending and a rebound in exports have helped the U.S. economy grow faster than economists...
Is A Man on the Inside Season 3 Confirmed? Everything We Know So Far
Upon the completion of Season 2 of the series A Man on the Inside, people started asking for the series’...
Top 10 Hottest Female Rappers in the World in 2026
Are you also interested in knowing who is the hottest and sexiest rapper in 2026 and where most of them...